Study of SDX in Patients With Idiopathic Hypersomnia (IH)
Trial details
- Registry ID
- NCT05668754
- Drugs studied
- Serdexmethylphenidate
TrialRedline tracks 1 clinical trial sponsored by Zevra Therapeutics: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of SDX in Patients With Idiopathic Hypersomnia (IH)NCT05668754 | Serdexmethylphenidate | Completed | 2024-02-28Actual |
Names as written in the registry records.
NCT05668754 · Zevra Therapeutics
Before: 164 participants (actual). After: 66 participants (actual).